Ensysce Biosciences Performance
| ENSCWDelisted Stock | USD 0.01 0.0008 8.16% |
The firm shows a Beta (market volatility) of -10.21, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Ensysce Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Ensysce Biosciences is expected to outperform it. Ensysce Biosciences right now shows a risk of 0.0%. Please confirm Ensysce Biosciences value at risk and the relationship between the skewness and relative strength index , to decide if Ensysce Biosciences will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ensysce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental indicators, Ensysce Biosciences is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 194.2 K |
Ensysce |
Ensysce Biosciences Relative Risk vs. Return Landscape
If you would invest 0.90 in Ensysce Biosciences on September 22, 2024 and sell it today you would earn a total of 0.00 from holding Ensysce Biosciences or generate 0.0% return on investment over 90 days. Ensysce Biosciences is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Ensysce, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ensysce Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ensysce Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ensysce Biosciences, and traders can use it to determine the average amount a Ensysce Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ENSCW |
Based on monthly moving average Ensysce Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ensysce Biosciences by adding Ensysce Biosciences to a well-diversified portfolio.
Ensysce Biosciences Fundamentals Growth
Ensysce Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ensysce Biosciences, and Ensysce Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ensysce Pink Sheet performance.
| EBITDA | (27.79 M) | ||||
| Total Debt | 4.44 M | ||||
| Cash Flow From Operations | (8.24 M) | ||||
| Total Asset | 16.42 M | ||||
About Ensysce Biosciences Performance
Evaluating Ensysce Biosciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Ensysce Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ensysce Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. Ensysce Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Ensysce Biosciences performance evaluation
Checking the ongoing alerts about Ensysce Biosciences for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ensysce Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ensysce Biosciences is not yet fully synchronised with the market data | |
| Ensysce Biosciences has some characteristics of a very speculative penny stock | |
| Ensysce Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (29.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ensysce Biosciences generates negative cash flow from operations |
- Analyzing Ensysce Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ensysce Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Ensysce Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ensysce Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ensysce Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ensysce Biosciences' pink sheet. These opinions can provide insight into Ensysce Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Ensysce Pink Sheet
If you are still planning to invest in Ensysce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ensysce Biosciences' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |